[1] Hoffman JI, Kaplan S.The incidence of congenital heart disease[J]. J Am Coll Cardiol, 2002,39:1890-1900. [2] 中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2021概要[J]. 中国循环杂志, 2022, 553-578. [3] Diller GP, Breithardt G, Baumgartner H.Congenital heart defects in adulthood[J]. Dtsch Arztebl Int, 2011,108:452-459. [4] Junghare SW, Desurkar V.Congenital heart diseases and anaesthesia[J]. Indian J Anaesth, 2017,61:744-752. [5] Baumgartner H, De Backer J, Babu-Narayan SV, et al. 2020 ESC Guidelines for the management of adult congenital heart disease[J]. Eur Heart J, 2021,42:563-645. [6] Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[J]. Circulation, 2019,139:e698-e800. [7] Taylor D, Habre W.Risk associated with anesthesia for noncardiac surgery in children with congenital heart disease[J]. Paediatr Anaesth, 2019,29:426-434. [8] Gaeta SA, Ward C, Krasuski RA.Extra-cardiac manifestations of adult congenital heart disease[J]. Trends Cardiovasc Med, 2016,26:627-636. [9] Baggen VJ, van den Bosch AE, Eindhoven JA, et al. Prognostic value of N-terminal pro-B-type natriuretic peptide, troponin-T, and growth-differentiation factor 15 in adult congenital heart disease[J]. Circulation, 2017,135:264-279. [10] Andrews JS, Hashmi NK.Anesthetic management in adults with congenital heart disease[J]. Curr Cardiol Rep, 2022,24:235-246. [11] Lill MC, Perloff JK, Child JS.Pathogenesis of thrombocytopenia in cyanotic congenital heart disease[J]. Am J Cardiol, 2006,98:254-258. [12] Mandalenakis Z, Rosengren A, Lappas G, et al. Ischemic stroke in children and young adults with congenital heart disease[J]. J Am Heart Assoc, 2016,5:e003071.doi: 10.1161/JAHA.115.003071. |